Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Curve type (GR values) Curve type (relative cell counts) Experiment name Number of concentrations Cell doublings (DMSO control) GR50 GRmax GR_AOC GEC50 GRinf Hill slope (GR values) R-squared sigmoid fit (GR values) P-value sigmoid fit (GR values) R-squared flat fit (GR values) IC50 Emax AUC EC50 Einf Hill slope (relative cell counts) R-squared sigmoid fit (relative cell counts) P-value sigmoid fit (relative cell counts) R-squared flat fit (relative cell counts)
BT-20 Omipalisib 3 72
sigmoid
sigmoid
BT20 omipalisib 0 3 72
8 2.586
0.00689
-0.587
0.893
0.044
-0.714
0.478
0.958
7.32e-05
NA
0.00572
0.017
0.281
0.00491
0.0669
0.945
0.983
4.7e-06
NA
BT-20 Dactolisib 2 72
sigmoid
sigmoid
BT20 dactolisib 0 2 72
8 1.727
0.00497
-0.212
0.896
0.00652
-0.186
1.17
0.995
1.45e-07
NA
0.00801
0.2
0.382
0.00505
0.211
1.19
0.994
2.07e-07
NA
BT-20 Omipalisib 1 72
sigmoid
sigmoid
BT20 omipalisib 0 1 72
8 2.078
0.00617
-0.729
0.985
0.0283
-0.739
0.596
0.97
2.83e-05
NA
0.00781
0.0157
0.306
0.00685
0.0597
0.96
0.988
1.57e-06
NA
BT-20 Torin2 2 72
sigmoid
sigmoid
BT20 Torin2 0 2 72
8 1.733
0.00315
-0.761
0.992
0.0484
-0.95
0.389
0.949
0.000131
NA
0.00804
0.0252
0.336
0.00642
0.0613
0.583
0.974
1.77e-05
NA
HCC70 Omipalisib 2 72
sigmoid
sigmoid
HCC70 omipalisib 0 2 72
8 1.682
0.00746
-0.705
1.01
0.0241
-0.703
0.749
0.991
6.69e-07
NA
0.0135
0.0399
0.359
0.0121
0.0458
0.852
0.989
1.45e-06
NA
BT-20 Omipalisib 2 72
sigmoid
sigmoid
BT20 omipalisib 0 2 72
8 1.717
0.00324
-0.799
1.1
0.00361
-0.354
4.99
0.808
0.00704
NA
0.00518
0.0194
0.291
0.00429
0.111
1.34
0.968
3.16e-05
NA
HCC70 Omipalisib 1 72
sigmoid
sigmoid
HCC70 omipalisib 0 1 72
8 1.358
0.00496
-0.785
1.14
0.0157
-0.775
0.812
0.989
1.34e-06
NA
0.0123
0.0486
0.349
0.011
0.0462
0.833
0.984
3.73e-06
NA